Clinical Trial Update: BIOFLOW-III All-comers Orsiro Safety and Performance Registry

View source ↗

Summary

This is a clinical trial update for the BIOFLOW-III Orsiro safety and performance registry sponsored by Biotronik, involving patients with coronary artery disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Orsiro (Sirolimus-eluting stent)

Snippet

Sponsor: Biotronik AG | Conditions: Coronary Artery Disease, Myocardial Ischemia | Status: UNKNOWN